Precigen surges after Q1 revenue beat, narrower loss
** Shares of drugmaker Precigen PGEN.O jumps 23.8% to $5.14 premarket ** PGEN late on Wednesday reported Q1 revenue of $23.25 million, beating analysts' average estimate of $20.8 million, according to data compiled by LSEG ** Net loss for the quarter narrowed to $7.93 million from $54.15 million a year earlier ** As of last close, PGEN stock was down 0.7% YTD (Reporting by Padmanabhan Ananthan) ((Padmanabhan.Ananthan@thomsonreuters.com))
Recent news on Precigen
See all newsBrief: Precigen Receives FDA Platform Technology Designation For Adenoverse Platform
Precigen, Inc. reports results for the quarter ended June 30 - Earnings Summary
Precigen posts quarterly profit as PAPZIMEOS sales surge
Precigen Inc expected to post a loss of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Advanced Energy, Bel Fuse, Cerebras